Acura Pharmaceuticals (STU:HD4B) Total Receivables: €0.14 Mil (As of Dec. 2021)


STU:HD4B Acura Pharmaceuticals Inc STU:HD4B
16 GF Score
Price €0.20
View Full Analysis

What is Acura Pharmaceuticals Total Receivables?

Acura Pharmaceuticals STU:HD4B 16 Total Receivables is €0.14 Mil as of Dec. 2021. GuruFocus rates STU:HD4B with a GF Score™ of 16/100.

Acura Pharmaceuticals's Total Receivables for the quarter that ended in Dec. 2021 was €0.14 Mil.

Acura Pharmaceuticals Total Receivables Related Terms

Acura Pharmaceuticals Total Receivables Historical Data

* Premium members only.

The historical data trend for Acura Pharmaceuticals's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acura Pharmaceuticals Total Receivables Chart

Acura Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.18 0.18 0.52 0.14

Acura Pharmaceuticals Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.79 0.93 0.46 0.14
STU:HD4B
16GF Score
Acura Pharmaceuticals Inc STU:HD4B
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acura Pharmaceuticals Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €0.14 Mil mean?
Acura Pharmaceuticals (STU:HD4B) has a Total Receivables of €0.14 Mil as of Dec. 2021. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Acura Pharmaceuticals and its competitors.
Is Acura Pharmaceuticals' Total Receivables too high?
Acura Pharmaceuticals' current Total Receivables is €0.14 Mil. Overall, Acura Pharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Acura Pharmaceuticals' Total Receivables compare to VFRM and THCT?
Acura Pharmaceuticals' Total Receivables of €0.14 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Acura Pharmaceuticals and its competitors. Acura Pharmaceuticals's current Total Receivables is €0.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acura Pharmaceuticals stock overvalued right now?
Acura Pharmaceuticals (STU:HD4B) has a current Total Receivables of €0.14 Mil. The current Total Receivables is €0.14 Mil. Acura Pharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Acura Pharmaceuticals (STU:HD4B), the current Total Receivables is €0.14 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acura Pharmaceuticals Business Description

Address 616 N. North Court, Suite 120, Palatine, IL, USA, 60067
Acura Pharmaceuticals Inc is a drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications. It has discovered and developed three proprietary platform technologies which can be used to develop multiple products. Its Limitx Technology is being developed to minimize the risk of overdose, its Aversion Technology is intended to address methods of abuse associated with opioid analgesics while its Impede Technology is directed at minimizing the extraction and conversion of pseudoephedrine, or PSE, into methamphetamine. It operates in single segment being the research, development and commercialization of technologies and products intended to address safe use of medications.
16GF Score

Get the complete analysis for STU:HD4B

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.20
Price